Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Biomaterials|June 24, 2018
Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer modelSteven K Jones, Kirk Douglas, Anthony F Shields, et al.
Cancer|January 28, 2004
Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trialAnthony F Shields, Mark M Zalupski, John L Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2014
Positron emission tomography for subsequent treatment strategy in oncologyLandis K Griffeth, Bruce E Hillner, Anthony F Shields, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studiesHaihao Sun, Jerry M Collins, Thomas J Mangner, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 18, 2019
Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian CancerDaniel P Feldmann, Steven Jones, Kirk Douglas, et al.
Nuclear Medicine and Biology|December 21, 2002
Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogsHaihao Sun, Jerry M Collins, Thomas J Mangner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2008
Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2Omid S Tehrani, Kirk A Douglas, Jawana M Lawhorn-Crews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogsSridhar Nimmagadda, Thomas J Mangner, Kirk A Douglas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2009
Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil)Sridhar Nimmagadda, Thomas J Mangner, Jawana M Lawhorn-Crews, et al.
Molecular Imaging and Biology|November 27, 2023
The First Human Application of an F-18-Labeled Tryptophan Analog for PET Imaging of CancerOtto Muzik, Anthony F Shields, Geoffrey R Barger, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Biomaterials|June 24, 2018
Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer modelSteven K Jones, Kirk Douglas, Anthony F Shields, et al.
Cancer|January 28, 2004
Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trialAnthony F Shields, Mark M Zalupski, John L Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2014
Positron emission tomography for subsequent treatment strategy in oncologyLandis K Griffeth, Bruce E Hillner, Anthony F Shields, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studiesHaihao Sun, Jerry M Collins, Thomas J Mangner, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 18, 2019
Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian CancerDaniel P Feldmann, Steven Jones, Kirk Douglas, et al.
Nuclear Medicine and Biology|December 21, 2002
Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogsHaihao Sun, Jerry M Collins, Thomas J Mangner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2008
Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2Omid S Tehrani, Kirk A Douglas, Jawana M Lawhorn-Crews, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2007
Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogsSridhar Nimmagadda, Thomas J Mangner, Kirk A Douglas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2009
Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[18F]fluoro-1-β-D-arabinofuranosyl)-5-uracil)Sridhar Nimmagadda, Thomas J Mangner, Jawana M Lawhorn-Crews, et al.
Molecular Imaging and Biology|November 27, 2023
The First Human Application of an F-18-Labeled Tryptophan Analog for PET Imaging of CancerOtto Muzik, Anthony F Shields, Geoffrey R Barger, et al.
Pageof 19